News

HDMA in testimony to Congress: Government, industry should partner on combating Rx drug abuse

BY Michael Johnsen

ARLINGTON, Va. — Healthcare Distribution Management Association president and CEO John Gray on Monday testified before the House Energy and Commerce Subcommittee on Health at a hearing on “Improving Predictability and Transparency in DEA and FDA Regulation.” HDMA is in support of the Ensuring Patient Access and Effective Drug Enforcement Act of 2014, H.R. 4069, sponsored by Reps. Marino, R-Pa., and Blackburn, R-Tenn. 

“The Marino-Blackburn legislation will further define key terminology in the Controlled Substances Act, so companies registered with the Drug Enforcement Administration have clearer direction of their responsibilities under the law," he testified. 

"A key provision allows DEA-registered companies to establish corrective action plans to address and mitigate any agency concerns — similar to the way FDA interacts and regulates pharmaceutical manufacturers — so industry and regulators can partner to address drug abuse and diversion. HDMA and our primary healthcare distributor members are working to identify collaborative and transparent solutions, in partnership with our supply chain trading partners and government officials, to slow the prescription drug abuse epidemic in our country, and the Marino-Blackburn bill is one step in our efforts to achieve that goal.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

NPA names former FDA director Daniel Fabricant CEO

BY Michael Johnsen

WASHINGTON — The Natural Products Association on Tuesday named Daniel Fabricant the association’s new CEO. Fabricant has worked as the director of the Division of Dietary Supplement Programs at the Food and Drug Administration for the past three years, and prior to that was VP global government and scientific affairs for NPA, including serving as active CEO for several months in 2009.  

“We couldn’t be more pleased that Dr. Fabricant will be returning to NPA. His service to this association in the past, coupled with the invaluable experience he has gathered at FDA, make him the perfect choice to lead our association in this era of growth,” stated NPA president Roxanne Green. “He knows the industry as well, if not better, than anyone. NPA is committed to ensuring that the public knows what is truly natural, that our members understand the complex rules and regulations governing our industry, and that policymakers get the facts. As the foremost industry expert on natural products and dietary supplement issues, Dr. Fabricant will help us achieve those goals.”

Fabricant has published extensively and is internationally recognized both for his regulatory and governmental public health expertise and natural products research. He is a sought after speaker, regular guest on national news programs and has testified before Congress. He was honored with the FDA Commissioners Award for his service on several different initiatives. His service at FDA required him to direct agency policy, public affairs and regulatory action regarding regulation of the $32 billion dietary supplement industry, a commodity used by over 180 million Americans daily.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Kinney Drugs changes name to better reflect business model

BY Antoinette Alexander

GOUVERNEUR, N.Y. — In an effort to more accurately reflect the makeup of Kinney Drugs’ diverse range of pharmacy-related health care services, the company has decided to change its name to KPH Healthcare Services.

“We believe that the name change will afford each of our divisions the best opportunity to grow business within existing markets, as well as position them for expansion into new markets,” the company said in a statement sent to Drug Store News.

The company stressed that there has been no change in the ownership structure of the company, and this name change will not affect the identity of its divisions. Each division will continue to use their current logos and will maintain their brand distinction, including the well-known Kinney Drugs name and logo long associated with its drug stores.

The KPH Healthcare Services business model includes four divisions:

  • Kinney Drugs, a chain of 100 drug stores located throughout New York and Vermont;
  • Health Direct Institutional Pharmacy Services, which services long-term care and alternative care needs;
  • ProAct Inc., a PBM company and mail-order pharmacy; and
  • Noble Health Services, a specialty pharmacy that dispenses medications used to treat complex and chronic diseases.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?